G1 Therapeutics Pre-Tax Profit Margin 2016-2024 | GTHX
G1 Therapeutics pre-tax profit margin from 2016 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2024-06-30 | $0.06B | $-0.04B | -72.41% |
| 2024-03-31 | $0.08B | $-0.03B | -32.53% |
| 2023-12-31 | $0.08B | $-0.05B | -54.88% |
| 2023-09-30 | $0.08B | $-0.07B | -88.31% |
| 2023-06-30 | $0.09B | $-0.08B | -84.27% |
| 2023-03-31 | $0.06B | $-0.12B | -213.79% |
| 2022-12-31 | $0.05B | $-0.15B | -278.85% |
| 2022-09-30 | $0.05B | $-0.15B | -316.67% |
| 2022-06-30 | $0.03B | $-0.17B | -586.21% |
| 2022-03-31 | $0.03B | $-0.17B | -680.00% |
| 2021-12-31 | $0.03B | $-0.15B | -459.38% |
| 2021-09-30 | $0.04B | $-0.13B | -306.98% |
| 2021-06-30 | $0.07B | $-0.10B | -155.38% |
| 2021-03-31 | $0.06B | $-0.09B | -155.00% |
